FDA Inspection 1181958 — Novum Pharmaceutical Research Services Inc.
The FDA completed an inspection of Novum Pharmaceutical Research Services Inc. on September 29, 2022 in Scarborough. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 29, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Scarborough (Canada)
Additional Details
Clinical BA/BE